LordsMed partnership with Hindustan Antibiotics To Distribute Rapid Antigen Kits

LordsMed: LordsMed, the healthcare division of Lord’s Mark Industries, has entered into a distribution partnership with Hindustan Antibiotics Limited (HAL), a public-sector drug manufacturer. The Healthcare company will manufacture rapid antigen test kits at its ICMR-approved GMP and ISO-certified facility at Vasai, near Mumbai, Maharashtra, and distribute those kits in government healthcare centres across India at an affordable rate 10 per cent less than the average market rates.

The Company said The broadening of the distribution network is part of LordsMed’s goal of facilitating early-stage healthcare intervention and generating Rs 75 crore in revenue in six months. LordsMed has recently received  Indian Council of Medical Research (ICMR) approval to manufacture rapid antigen test kits at its Vasai facility for detecting malaria, cardiovascular disease, hepatitis C virus (HCV), HIV, syphilis, hepatitis B surface antigen (HBsAg), dengue, typhoid, COVID, chikungunya, ovulation, and pregnancy.

LordsMed said it has developed a robust R&D team comprised of experienced microbiologists and doctors and has emerged as the only IVD kit manufacturing company in India, working to roll out saliva-based diagnostic solutions for a range of diseases. The company has successfully carried out trials of its saliva-based diagnostics kits for diabetes and liver diseases.

Commenting on the partnership with HAL, Sachidanand Upadhyay, Founder, Lord’s Mark Industries, said, The distribution partnership with HAL will help us reach out to all parts of the country cities including metros, Tier -1, 2 and 3 cities and rural areas with our affordable and advanced rapid antigen test kits. The collaboration is a part of our mission to build a robust early-stage healthcare intervention framework and boost the responsiveness of the healthcare ecosystem.

The company stated its future plans to set up a manufacturing unit in Gujarat by 2023 and another facility in Lucknow, Uttar Pradesh, by 2024 to further boost its manufacturing capabilities and serve the growing market demand. The company also has plans to expand its exports to all countries in Africa and Europe.

Related Posts

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

New Delhi: Even as global economic uncertainty drags down trade, Indian pharmaceutical exporters are seeing growth in Brazil and Nigeria as both countries are emerging as important overseas markets. Data…

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

Lucknow: Chief Minister Yogi Adityanath on Sunday said that Uttar Pradesh is not merely a state with a population of 25 crore but has also emerged as the country’s largest hub…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

UP has emerged as India’s largest Healthcare & med tech hub: Yogi

Centre flags serious lapses in state’s blood banks

Centre flags serious lapses in state’s blood banks

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Controlled substances charge: Court summons Ramdev, Amazon founder

Controlled substances charge: Court summons Ramdev, Amazon founder